Work in process

Current Assets

Eli Lilly Work in process increased by 11.8% to $7.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.3%, from $4.04B to $7.27B.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2023
Last reportedQ3 2025
Parent metricInventories
Metric ID: inv_work_in_progress

Historical Data

8 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$3.25B$3.61B$3.71B$4.04B$3.98B$5.30B$6.51B$7.27B
QoQ Change+11.2%+2.6%+8.9%-1.4%+33.1%+22.9%+11.8%
YoY Change+22.5%+46.6%+75.6%+80.3%
% of Inventories56.3%60.1%58.0%54.6%52.4%57.1%59.1%59.5%
Share Change+3.9pp-2.2pp-3.3pp-2.2pp+4.6pp+2.0pp+0.4pp
Range$3.25B$7.27B
CAGR+58.5%
Avg YoY Growth+56.3%
Median YoY Growth+61.1%
Current Streak3 quarters growth

Work in process at Other Companies

Frequently Asked Questions

What is Eli Lilly's work in process?
Eli Lilly (LLY) reported work in process of $7.27B in Q3 2025.
How has Eli Lilly's work in process changed year-over-year?
Eli Lilly's work in process increased by 80.3% year-over-year, from $4.04B to $7.27B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.